Michael Gilman has been in this position before. About 10 years ago, he left an executive research position at Biogen Idec, hooked up with Atlas Venture, and formed (Read more...)
Bellicum Pharmaceuticals has made a little bit of Houston history. In becoming the latest in a new wave of cancer immunotherapy companies to go public, Bellicum has managed (Read more...)
Companies in healthcare IT have been percolating for the past five-plus years.
Now, with the regulatory climate evolving and big companies like Apple getting more serious about (Read more...)
Accelerate Long Island seeded its first batch of startups earlier this year, and today it has circled back with its latest investment—a company purporting to use computer tools (Read more...)
How’s this for strange? What’s likely the most important biotech patent battle of the decade is now being fought under outmoded rules that the U.S. Congress, in (Read more...)
With 2014 coming to a close, it’s an appropriate time to reflect on the past year. That’s especially true for me today, as Xconomy celebrates the one-year anniversary (Read more...)
Former employees of Elan, the Irish-American drug company that grabbed plenty of headlines before it was broken into parts, have launched a company to develop monoclonal antibodies to (Read more...)
How alluring is the pull of industry these days? Vertex Pharmaceuticals just got one of the world’s top geneticists, a founder of the Broad Institute of MIT and (Read more...)
Tony Coles could easily be on a beach sipping mai tais right now. You can plan for an early retirement in biotech when you turn two different biotechs (Read more...)
Ambitions for biologically sourced fuels bump up against the reality that making chemicals and fuels from organic material is still generally more expensive. One company is hoping to (Read more...)
The Texas Medical Center hosted a dozen digital health startups this week as part of a program with Village Capital, a Washington, DC-based venture firm.
The program, called (Read more...)
Oncothyreon and Array BioPharma announced today that they have updated their development agreement around a breast cancer drug invented by Array.
Oncothyreon, based in Seattle, will pay (Read more...)
Boston’s stock as an innovation cluster is on the rise. At least in the eyes of the outside world. In addition to increased interest in the region’s (Read more...)
Ebola research has yet to yield a proven vaccine or antiviral drug but the work done so far could be paving the way for something else—faster and more (Read more...)
Add the Mayo Clinic to the list of companies, entrepreneurs, and investors that are in Techstars’s seemingly ever-growing network.
The Boulder, CO-based startup accelerator announced today that it (Read more...)